Serologic and molecular diagnosis of hepatitis B virus

Clinics in Liver Disease

Volumn 8, Issue 2, 2004, Pages 267-281

  Servoss, Julie C ^a,b   Friedman, Lawrence S ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NEWTON WELLESLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; MOLECULAR MARKER; VIRUS DNA;

ACUTE DISEASE; AMINO ACID SUBSTITUTION; ANALYTICAL EQUIPMENT; CHRONIC DISEASE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DNA DETERMINATION; EXPOSURE; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENOME ANALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; LABORATORY TEST; OPEN READING FRAME; PATIENT; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; SEROCONVERSION; SERODIAGNOSIS; SEROLOGY; SYMPTOM; VIRUS DETECTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS TITRATION;

DNA, VIRAL; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 2942530701     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2004.02.001     Document Type: Review

References (24)

1. Cabrerizo M., Bartolome J., Caramelo C., Barril G., Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology. 32:2000;116-123
2. Lok A.S.F., McMahon B.J. Chronic hepatitis B. Hepatology. 34:2001;1225-1241
3. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Toshiba M., Moriyama K., et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol. 68:1994;8102-8110
4. Laskus T., Rakela J., Nowicki M.J., Pershing D.H. Hepatitis B core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology. 109:1995;1618-1623
5. Martin P., Friedman L.S., Dienstag J.L. Diagnostic approach. Zuckerman A.J., Thomas H.C. Viral hepatitis: scientific basis and clinical management. 1993;393-408 Churchill Livingstone, Edinburgh
6. CDC Sensitivity of the test for antibody to hepatitis B surface antigen - United States. MMWR. 42:1993;707-710
7. Berenguer M., Wright T.L. Viral hepatitis. Feldman M., Friedman L.S., Sleisenger M.H. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology diagnosis management. 7th edition:2002;1278-1341 W.B. Saunders, Philadelphia
8. Gandhi R.T., Wurcel A., Lee H., McGovern B., Boczanowski M., Gerwin R., et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis. 36:2003;1602-1605
9. Douglas D.D., Taswell H.F., Rakela J., Rabe D. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion. 33:1993;212-216
10. Silva A.E., McMahon B.J., Parkinson A.J., Sjogren M.H., Hoofnagle J.H., Di Bisceglie A.M. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis. 26:1998;895-897
11. Chung H.T., Lee S.T.K., Lok A.S.F. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Hepatology. 18:1993;1045-1049
12. Lok A.S., Heathcote E.J., Hoofnagle J.H. Management of hepatitis B 2000: summary of a workshop. Gastroenterology. 120:2001;1828-1853
13. Hadziyannis S.J. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepat Rev. 1:1995;7-36
14. Pawlotsky J.M. Molecular diagnosis of viral hepatitis. Gastroenterology. 122:2002;1554-1568
15. Hu K.Q., Vierling J.M. Molecular diagnostic techniques for viral hepatitis. Gastroenterol Clin North Am. 23:1994;479-498
16. Barlet V., Cohard M., Thelu M.A., Chaix M.J., Baccard C., Zarski J.P., et al. Quantitative detection of hepatitis B virus DNA in serum using chemiluminescence: comparison of radioactive solution hybridization assay. J Virol Methods. 49:1994;141-151
17. Digene Corporation Website Hybrid Capture Technology. Available at: http://www.digene.com. Accessed December 1, 2003
18. Urdea M.S., Horn T., Fultz T.J., Anderson M., Running J.A., Hamren S., et al. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Symp Ser. 24:1991;197-200
19. Loeb K.R., Jerome K.R., Goddard J., Huang M., Cent A., Corey L. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology. 32:2000;626-629
20. Ho S.K.N., Yam W., Leung E.T.K., Wong L., Leung J.K.H., Lai K., et al. Rapid quantification of hepatitis B virus DNA by real-time PCR using fluorescent hybridization probes. J Med Microbiol. 52:2003;397-402
21. Higuchi R., Fockler C., Dollinger G., Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY). 11:1993;1026-1030
22. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994
23. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6:1996;995-1001
24. Saldanha J., Gerlich W., Lelie N., Dawson P., Heermann K., Heath A. WHO Collaborative Study Group An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang. 80:2001;63-71